Cancer Control & Population Sciences
Cancer Therapeutics & Host Response
Cancer Control & Population Sciences
Indelicato DJ, Vega RBM, Viviers E, Morris CG, Bradfield SM, Ranalli NJ, Bradley JA. Modern Therapy for Spinal and Paraspinal Ewing Sarcoma: An Update of the XXX Experience. Int J Radiat Oncol Biol Phys. 2022 Jan 13. pii: S0360-3016(22)00017-7. doi: 10.1016/j.ijrobp.2022.01.007. [Epub ahead of print] PubMed PMID: 35033584.
Cheng TD, Chaudhari PV, Bitsie KR, Striley CW, Varma DS, Cottler LB. The HealthStreet Cancer Survivor Cohort: a Community Registry for Cancer Research. J Cancer Surviv. 2022 Jan 28. doi: 10.1007/s11764-022-01173-4. [Epub ahead of print] PubMed PMID: 35089522.
Guru Murthy GS, Kim S, Hu ZH, Estrada-Merly N, Abid MB, Aljurf M, Bacher U, Badawy SM, Beitinjaneh A, Bredeson C, Cahn JY, Cerny J, Diaz Perez MA, Farhadfar N, Gale RP, Ganguly S, Gergis U, Hildebrandt GC, Grunwald MR, Hashmi S, Hossain NM, Kalaycio M, Kamble RT, Kharfan-Dabaja MA, Hamilton BK, Lazarus HM, Liesveld J, Litzow M, Marks DI, Murthy HS, Nathan S, Nazha A, Nishihori T, Patel SS, Pawarode A, Rizzieri D, Savani B, Seo S, Solh M, Ustun C, van der Poel M, Verdonck LF, Vij R, Wirk B, Oran B, Nakamura R, Scott B, Saber W. Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors. JAMA Oncol. 2022 Jan 13. doi: 10.1001/jamaoncol.2021.6846. [Epub ahead of print] PubMed PMID: 35024768; PubMed Central PMCID: PMC8759031.
Park H, Lo-Ciganic WH, Huang J, Wu Y, Henry L, Peter J, Sulkowski M, Nelson DR. Machine Learning Algorithms for Predicting Direct-Acting Antiviral Treatment Failure in Chronic Hepatitis C: An HCV-TARGET Analysis. Hepatology. 2022 Jan 16. doi: 10.1002/hep.32347. [Epub ahead of print] PubMed PMID: 35034373.
Karanth SD, Katsumata Y, Nelson PT, Fardo DW, McDowell JK, Schmitt FA, Kryscio RJ, Browning SR, Braithwaite D, Arnold SM, Abner EL. Cancer diagnosis is associated with a lower burden of dementia and less Alzheimer’s-type neuropathology. Brain. 2022 Jan 30. pii: awac035. doi: 10.1093/brain/awac035. [Epub ahead of print] PubMed PMID: 35094057.
Arthur RS, Mossavar-Rahmani Y, Prentice RL, Shadyab AH, Luo J, Sattari M, Xue X, Kamensky V, Chen GC, Qi Q, Anderson GL, Wassertheil-Smoller S, Neuhouser ML, Rohan TE. The association of predicted resting energy expenditure with risk of breast cancer among postmenopausal women in the Women’s Health Initiative cohort. Cancer Prev Res (Phila). 2022 Jan 10. pii: canprevres.0467.2021. doi: 10.1158/1940-6207.CAPR-21-0467. [Epub ahead of print] PubMed PMID: 35012972.
Du X, Aristizabal-Henao JJ, Garrett TJ, Brochhausen M, Hogan WR, Lemas DJ. A Checklist for Reproducible Computational Analysis in Clinical Metabolomics Research. Metabolites. 2022 Jan 17;12(1). pii: 87. doi: 10.3390/metabo12010087. Review. PubMed PMID: 35050209; PubMed Central PMCID: PMC8779534.
Xing S, Shin J, Pursley J, Correa Alfonso CM, Depauw N, Domal S, Withrow J, Bolch WE, Grassberger C, Paganetti H. A dynamic blood flow model to compute absorbed dose to circulating blood and lymphocytes in liver external beam radiotherapy. Phys Med Biol. 2022 Jan 21. doi: 10.1088/1361-6560/ac4da4. [Epub ahead of print] PubMed PMID: 35061601.
Schoppee TM, Scarton L, Bluck S, Yao Y, Keenan G, Samuels V, Fitchett G, Handzo G, Chochinov HM, Emanuel LL, Wilkie DJ. Dignity therapy intervention fidelity: a cross-sectional descriptive study with older adult outpatients with cancer. BMC Palliat Care. 2022 Jan 11;21(1):8. doi: 10.1186/s12904-021-00888-y. PubMed PMID: 35016670; PubMed Central PMCID: PMC8751346.
Velazquez AI, Durani U, Weeks LD, Major A, Reynolds R, Kumbamu A, Das DG, Murphy MC, Henry E, Lee AI, Marshall AL. Impact of COVID-19 on Hematology-Oncology Fellowship Programs: A Quantitative and Qualitative Survey Assessment of Fellowship Program Directors. JCO Oncol Pract. 2022 Jan 11:OP2100634. doi: 10.1200/OP.21.00634. [Epub ahead of print] PubMed PMID: 35015586.
Durani U, Major A, Velazquez AI, May J, Nelson M, Zheng Z, Hall AG, Alam ST, Reynolds R, Thompson JC, Kumbamu A, Das DG, Murphy MC, Henry E, Lee AI, Marshall AL, Wun T, Weeks LD. Impact of COVID-19 on Hematology-Oncology Trainees: A Quantitative and Qualitative Assessment. JCO Oncol Pract. 2022 Jan 6:OP2100630. doi: 10.1200/OP.21.00630. [Epub ahead of print] PubMed PMID: 34990292.
Yang GS, Starkweather AR, Kelly DL, Meegan T, Byon HD, Lyon DE. Longitudinal Analysis of Sleep Disturbance in Breast Cancer Survivors. Nurs Res. 2022 Jan 12. doi: 10.1097/NNR.0000000000000578. [Epub ahead of print] PubMed PMID: 35026802.
Drescher NR, Amdur RJ, Morris CG, Shaw CM, Dziegielewski PT, Mendenhall WM. Postoperative radiotherapy for cutaneous melanoma in patients at high risk of local-regional recurrence after surgery alone. Cancer Invest. 2022 Jan 31:1-10. doi: 10.1080/07357907.2022.2033986. [Epub ahead of print] PubMed PMID: 35100059.
Cardenas-Goicoechea J, Wang YU, Lee JH, Shoraka M, Carbajal-Mamani SL, Fishman D, Riner AN, Trevino JG. Survival After Minimally Invasive Surgery in Older Women With Endometrial Carcinoma. Anticancer Res. 2022 Jan;42(1):75-85. doi: 10.21873/anticanres.15459. PubMed PMID: 34969711.
Liu C, Bradley JA, Zheng D, Vega RBM, Beltran CJ, Mendenhall N, Liang X. RBE-weighted dose and its impact on the risk of acute coronary event for breast cancer patients treated with intensity modulated proton therapy. J Appl Clin Med Phys. 2022 Jan 21. doi: 10.1002/acm2.13527. [Epub ahead of print] PubMed PMID: 35060317.
Hochhegger B, Camargo S, da Silva Teles GB, Chate RC, Szarf G, Guimarães MD, Gross JL, Barbosa PNVP, Chiarantano RS, Reis RM, Mauad EC, Ghefter M, Sarmento P, Pereira R, Rocha J, Albuquerque ML, Miotto A, Almeida Dias DC, Franceschini JP, Fernando HC, Dos Santos RS. Challenges of Implementing Lung Cancer Screening in a Developing Country: Results of the Second Brazilian Early Lung Cancer Screening Trial (BRELT2). JCO Glob Oncol. 2022 Jan;8:e2100257. doi: 10.1200/GO.21.00257. PubMed PMID: 35073147; PubMed Central PMCID: PMC8789215.
Suk R, Hong YR, Rajan SS, Xie Z, Zhu Y, Spencer JC. Assessment of US Preventive Services Task Force Guideline-Concordant Cervical Cancer Screening Rates and Reasons for Underscreening by Age, Race and Ethnicity, Sexual Orientation, Rurality, and Insurance, 2005 to 2019. JAMA Netw Open. 2022 Jan 4;5(1):e2143582. doi: 10.1001/jamanetworkopen.2021.43582. PubMed PMID: 35040970.
Murthy HS, Ahn KW, Estrada-Merly N, Alkhateeb HB, Bal S, Kharfan-Dabaja MA, Dholaria B, Foss F, Gowda L, Jagadeesh D, Sauter C, Abid MB, Aljurf M, Awan FT, Bacher U, Badawy SM, Battiwalla M, Bredeson C, Cerny J, Chhabra S, Deol A, Diaz MA, Farhadfar N, Freytes C, Gajewski J, Gandhi MJ, Ganguly S, Grunwald MR, Halter J, Hashmi S, Hildebrandt GC, Inamoto Y, Jimenez-Jimenez AM, Kalaycio M, Kamble R, Krem MM, Lazarus HM, Lazaryan A, Maakaron J, Munshi PN, Munker R, Nazha A, Nishihori T, OIuwole OO, Ortà G, Pan DC, Patel SS, Pawarode A, Rizzieri D, Saba NS, Savani B, Seo S, Ustun C, van der Poel M, Verdonck LF, Wagner JL, Wirk B, Oran B, Nakamura R, Scott B, Saber W. Outcomes of Allogeneic Hematopoietic Cell Transplantation in T-cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research. Transplant Cell Ther. 2022 Jan 23. pii: S2666-6367(22)00036-7. doi: 10.1016/j.jtct.2022.01.017. [Epub ahead of print] PubMed PMID: 35081472.
Cancer Therapeutics & Host Response
Elsayed AH, Cao X, Mitra AK, Wu H, Raimondi S, Cogle C, Al-Mansour Z, Ribeiro RC, Gamis A, Kolb EA, Aplenc R, Alonzo TA, Meshinchi S, Rubnitz J, Pounds S, Lamba JK. Polygenic Ara-C Response Score Identifies Pediatric Patients With Acute Myeloid Leukemia in Need of Chemotherapy Augmentation. J Clin Oncol. 2022 Jan 6:JCO2101422. doi: 10.1200/JCO.21.01422. [Epub ahead of print] PubMed PMID: 34990262.
Law ME, Davis BJ, Ghilardi AF, Yaaghubi E, Dulloo ZM, Wang M, Guryanova OA, Heldermon CD, Jahn SC, Castellano RK, Law BK. Repurposing Tranexamic Acid as an Anticancer Agent. Front Pharmacol. 2022 Jan 13;12:792600. doi: 10.3389/fphar.2021.792600. eCollection 2021. PubMed PMID: 35095503; PubMed Central PMCID: PMC8793890.
O’Brien MM, Ji L, Shah NN, Rheingold SR, Bhojwani D, Yuan CM, Xu X, Yi JS, Harris AC, Brown PA, Borowitz MJ, Militano O, Kairalla J, Devidas M, Raetz EA, Gore L, Loh ML. Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children’s Oncology Group Protocol AALL1621. J Clin Oncol. 2022 Jan 10:JCO2101693. doi: 10.1200/JCO.21.01693. [Epub ahead of print] PubMed PMID: 35007127.
Subbiah IM, Markham MJ, Graff SL, Matt-Amaral LB, Close JL, Griffith KA, Jagsi R. Incidence, Nature, and Consequences of Oncologists’ Experiences With Sexual Harassment. J Clin Oncol. 2022 Jan 28:JCO2102574. doi: 10.1200/JCO.21.02574. [Epub ahead of print] PubMed PMID: 35089804.
Lamba JK, Pounds S. Proteomics: a new era in pediatric acute myeloid leukemia research. Haematologica. 2022 Jan 13. doi: 10.3324/haematol.2021.280305. [Epub ahead of print] PubMed PMID: 35021610.
Indelicato DJ, Vega RBM, Viviers E, Morris CG, Bradfield SM, Ranalli NJ, Bradley JA. Modern Therapy for Spinal and Paraspinal Ewing Sarcoma: An Update of the XXX Experience. Int J Radiat Oncol Biol Phys. 2022 Jan 13. pii: S0360-3016(22)00017-7. doi: 10.1016/j.ijrobp.2022.01.007. [Epub ahead of print] PubMed PMID: 35033584.
Lucas JT Jr, Faught AM, Hsu CY, Wilson LJ, Guo Y, Li Y, Khan R, Becksfort JB, LeVine DA, Ismael Y, Darrow K, Moskvin VP, Pirlepesov F, Klimo P, Elijovich L, Indelicato DJ, Boop FA, Merchant TE. Pre- and Post-therapy Risk Factors for Vasculopathy in Pediatric Craniopharyngioma Patients Treated with Surgery and Proton Radiotherapy. Int J Radiat Oncol Biol Phys. 2022 Jan 3. pii: S0360-3016(21)03445-3. doi: 10.1016/j.ijrobp.2021.12.172. [Epub ahead of print] PubMed PMID: 34990778.
Watts J, Lin TL, Mims A, Patel P, Lee C, Shahidzadeh A, Shami P, Cull E, Cogle CR, Wang E, Uckun FM. Post-hoc Analysis of Pharmacodynamics and Single-Agent Activity of CD3xCD123 Bispecific Antibody APVO436 in Relapsed/Refractory AML and MDS Resistant to HMA or Venetoclax Plus HMA. Front Oncol. 2022 Jan 13;11:806243. doi: 10.3389/fonc.2021.806243. eCollection 2021. PubMed PMID: 35096610; PubMed Central PMCID: PMC8793782.
Mori V, Bates JHT, Jantz M, Mehta HJ, Kinsey CM. A computational modeling approach for dosing endoscopic intratumoral chemotherapy for advanced non-small cell lung cancer. Sci Rep. 2022 Jan 7;12(1):44. doi: 10.1038/s41598-021-03849-w. PubMed PMID: 34996946; PubMed Central PMCID: PMC8741990.
Liang C, Huang M, Li T, Li L, Sussman H, Dai Y, Siemann DW, Xie M, Tang X. Towards an integrative understanding of cancer mechanobiology: calcium, YAP, and microRNA under biophysical forces. Soft Matter. 2022 Jan 28. doi: 10.1039/d1sm01618k. [Epub ahead of print] Review. PubMed PMID: 35089300.
Du X, Aristizabal-Henao JJ, Garrett TJ, Brochhausen M, Hogan WR, Lemas DJ. A Checklist for Reproducible Computational Analysis in Clinical Metabolomics Research. Metabolites. 2022 Jan 17;12(1). pii: 87. doi: 10.3390/metabo12010087. Review. PubMed PMID: 35050209; PubMed Central PMCID: PMC8779534.
Gaito S, Burnet N, Aznar M, Crellin A, Indelicato DJ, Ingram S, Pan S, Price G, Hwang E, France A, Smith E, Whitfield G. Normal Tissue Complication Probability Modelling for Toxicity Prediction and Patient Selection in Proton Beam Therapy to the Central Nervous System: A Literature Review. Clin Oncol (R Coll Radiol). 2022 Jan 15. pii: S0936-6555(21)00514-8. doi: 10.1016/j.clon.2021.12.015. [Epub ahead of print] PubMed PMID: 35042622.
Xing C, Hati S, Hu Q, Huo Z, Lu J. In vivo structure-activity relationship of dihydromethysticin in reducing NNK-induced lung DNA damage against lung carcinogenesis. ChemMedChem. 2022 Jan 21. doi: 10.1002/cmdc.202100727. [Epub ahead of print] PubMed PMID: 35064644.
Kang H, Ben-David K, Sarosi GA, Thomas RM. Routine Radiologic Assessment for Anastomotic Leak Is Not Necessary in Asymptomatic Patients After Esophagectomy for Esophageal Cancer. J Gastrointest Surg. 2022 Jan 17. doi: 10.1007/s11605-021-05219-3. [Epub ahead of print] PubMed PMID: 35037179.
Drescher NR, Amdur RJ, Morris CG, Shaw CM, Dziegielewski PT, Mendenhall WM. Postoperative radiotherapy for cutaneous melanoma in patients at high risk of local-regional recurrence after surgery alone. Cancer Invest. 2022 Jan 31:1-10. doi: 10.1080/07357907.2022.2033986. [Epub ahead of print] PubMed PMID: 35100059.
Cardenas-Goicoechea J, Wang YU, Lee JH, Shoraka M, Carbajal-Mamani SL, Fishman D, Riner AN, Trevino JG. Survival After Minimally Invasive Surgery in Older Women With Endometrial Carcinoma. Anticancer Res. 2022 Jan;42(1):75-85. doi: 10.21873/anticanres.15459. PubMed PMID: 34969711.
Ackerman LH, de Mello Souza CH, Cort̩s-Hinojosa G, Salute ME, Stephen AA, Anthony E, Shiomitsu K, Milner RJ. Identification of the interleukin-8 (CXCL-8) pathway in feline oral squamous cell carcinoma РA pilot study. Can J Vet Res. 2022 Jan;86(1):13-19. PubMed PMID: 34975217; PubMed Central PMCID: PMC8697325.
Chan CM, Lindsay AD, Spiguel ARV, Parker Gibbs C, Scarborough MT. Why Rotationplasty? A Qualitative Study of Decision-Making by Families of Patients With Primary Bone Sarcoma. J Patient Exp. 2022 Jan 4;9:23743735211069818. doi: 10.1177/23743735211069818. eCollection 2022. PubMed PMID: 35005220; PubMed Central PMCID: PMC8733356.
Mechanisms of Oncogenesis
Liang C, Huang M, Li T, Li L, Sussman H, Dai Y, Siemann DW, Xie M, Tang X. Towards an integrative understanding of cancer mechanobiology: calcium, YAP, and microRNA under biophysical forces. Soft Matter. 2022 Jan 28. doi: 10.1039/d1sm01618k. [Epub ahead of print] Review. PubMed PMID: 35089300.
Ferrall-Fairbanks MC, Chakiryan N, Chobrutskiy BI, Kim Y, Teer JK, Berglund A, Mulé JJ, Fournier M, Siegel EM, Dhillon J, Falasiri SSA, Arturo JF, Katende EN, Blanck G, Manley BJ, Altrock PM. Quantification of T- and B-cell immune receptor distribution diversity characterizes immune cell infiltration and lymphocyte heterogeneity in clear cell renal cell carcinoma. Cancer Res. 2022 Jan 14. pii: canres.1747.2021. doi: 10.1158/0008-5472.CAN-21-1747. [Epub ahead of print] PubMed PMID: 35031572.
Law ME, Davis BJ, Ghilardi AF, Yaaghubi E, Dulloo ZM, Wang M, Guryanova OA, Heldermon CD, Jahn SC, Castellano RK, Law BK. Repurposing Tranexamic Acid as an Anticancer Agent. Front Pharmacol. 2022 Jan 13;12:792600. doi: 10.3389/fphar.2021.792600. eCollection 2021. PubMed PMID: 35095503; PubMed Central PMCID: PMC8793890.
Preston SEJ, Emond A, Pettersson F, Dupéré-Richer D, Abraham MJ, Riva A, Kinal M, Rys R, Johnson NA, Mann KK, Del Rincon SV, Licht JD, Miller WH. Acquired resistance to EZH2 inhibitor GSK343 promotes the differentiation of human DLBCL cell lines towards an ABC-like phenotype. Mol Cancer Ther. 2022 Jan 27. pii: molcanther.0216.2021. doi: 10.1158/1535-7163.MCT-21-0216. [Epub ahead of print] PubMed PMID: 35086959.
Du X, Aristizabal-Henao JJ, Garrett TJ, Brochhausen M, Hogan WR, Lemas DJ. A Checklist for Reproducible Computational Analysis in Clinical Metabolomics Research. Metabolites. 2022 Jan 17;12(1). pii: 87. doi: 10.3390/metabo12010087. Review. PubMed PMID: 35050209; PubMed Central PMCID: PMC8779534.
Reinhart NM, Akinyemi IA, Frey TR, Xu H, Agudelo C, Brathwaite J, Burton EM, Burgula S, McIntosh MT, Bhaduri-McIntosh S. The danger molecule HMGB1 cooperates with the NLRP3 inflammasome to sustain expression of the EBV lytic switch protein in Burkitt lymphoma cells. Virology. 2022 Jan;566:136-142. doi: 10.1016/j.virol.2021.12.002. Epub 2021 Dec 3. PubMed PMID: 34922257.